MedTrace Logo

Utility of Amantadine Hydrochloride in the Treatment of Post-traumatic Irritability

NCT00627250 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2022-04-25

No results posted yet for this study

Summary

The purpose of this study is to determine if amantadine hydrochloride given 100 mg in the morning and at noon is safe and effective in the treatment of mood and behavior changes (i.e. irritability) after sustaining traumatic brain injury.

Conditions

Interventions

DRUG

Amantadine

Amantadine 100 mg every morning and 12 noon

Sponsors & Collaborators

  • U.S. Department of Education

    collaborator FED

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Flora M Hammond, M.D. · Carolinas Rehabilitation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-03-31
Primary Completion
2007-11-30
Completion
2007-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00627250 on ClinicalTrials.gov